Securities code: Aoshikang Technology Co.Ltd(002913) securities abbreviation: Aoshikang Technology Co.Ltd(002913) Announcement No.: 2022026 Aoshikang Technology Co.Ltd(002913)
Special report on the deposit and actual use of raised funds in 2021
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
According to the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies (revised in 2022) and the guidelines for the self discipline supervision of listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board (hereinafter referred to as “standardized operation of the main board”) issued by the China Securities Regulatory Commission The board of directors of Aoshikang Technology Co.Ltd(002913) (hereinafter referred to as “the company” or “the company”) prepared a special report on the annual deposit and actual use of raised funds as of December 31, 2021.
1、 Basic information of raised funds
(I) IPO in 2017
(1) Actual amount of raised funds and arrival time of funds
Approved by the reply on approving Aoshikang Technology Co.Ltd(002913) initial public offering (zjxk [2017] No. 1990) of China Securities Regulatory Commission, the company publicly issued 3601300000 RMB ordinary shares (A shares) to the public at Shenzhen Stock Exchange in November 2017, with an issue price of 30.38 yuan / share and a total raised capital of 109407494000 yuan, After deducting the recommendation and underwriting expenses of 5670374700 yuan, the balance is 103737119300 yuan. In addition, after deducting the intermediary fees and other issuance expenses of 1023599244 yuan, the net amount of funds actually raised is 102713520056 yuan. The above funds were put in place on November 28, 2017. The situation has been verified by Tianzhi International Certified Public Accountants (special general partnership), and the capital verification report (Tian Zhi Ye Zi [2017] No. 18334) was issued on November 28, 2017.
(2) Amount used in the current year and year-end balance
The company has used a total of 102395532805 yuan of raised funds, including 87443511862 yuan in the previous year and 14952020943 yuan in the current year. Whereas the “construction project of automobile electronic printed circuit board with an annual output of 800000 square meters” has been closed and the relevant special account for raised funds has been cancelled,
The balance of 9 Harbin Pharmaceutical Group Co.Ltd(600664) 4 yuan in the account was transferred to the basic account of the company to supplement working capital. As of December 31, 2021, the balance of the company’s special account for raised funds was RMB 727023158, and the balance of some idle raised funds temporarily replenishing working capital was RMB 65 million.00. The situation over the years is as follows:
Project amount
The total amount of funds raised on November 28, 2017 was 103737119300 less: issuance expenses 1023599244 net amount of funds raised on November 28, 2017 was 102713520056 plus: interest income of 201720803947 issuance expenses not yet transferred 862245283 minus: 16315764813 accumulated funds used in 2017, including 15020944218217 self raised funds used in 20171294820595 as of December 31, 2017, the balance of raised funds was 87280804473 plus: the net amount of interest income and bank wealth management income in 2018 after deducting bank handling charges was 2625116885 minus: the accumulated use of raised funds in 201826070724262 less: in 2018, 862245283 of the issuance expenses that had not been transferred in the previous period were transferred. As of December 31, 2018, the balance of raised funds was 62972951813 plus: the net amount of interest income and bank wealth management income in 2019 after deducting bank handling charges was 2269509027 less: the accumulated amount of interest income in 2019 With the raised funds 11880987609, as of December 31, 2019, the balance of raised funds was 53361473231, including the deposit balance of 52700000000 special account for purchased bank financial management 661473231 plus: 1642163936 net amount of interest income and bank wealth management income deducting bank service charges in 2020 minus: 3317 Juewei Food Co.Ltd(603517) 8 accumulated raised funds used in 2020, 21827 China Shipbuilding Industry Company Limited(601989) balance of raised funds as of December 31, 2020
Project amount
Including: deposit balance of 18500000000 special account for purchase of bank financing funds 3327 China Shipbuilding Industry Company Limited(601989) plus: net amount of 2021 interest income and bank financing income after deducting bank handling charges 447448756 minus: accumulated use of raised funds in 202114952020943 minus: account cancellation, The balance fund was transferred into working capital 9 Harbin Pharmaceutical Group Co.Ltd(600664) 4. As of December 31, 2021, the balance of raised funds was 7227023158, including: the deposit balance of special account for raised funds was 727023158, including: temporarily replenishing working capital 6500000000 (Ⅱ) non public offering of A-Shares in 2020
(1) Actual amount of raised funds and arrival time of funds
Approved by the reply on approving Aoshikang Technology Co.Ltd(002913) non-public Development Bank shares (zjxk [2020] No. 3571) of China Securities Regulatory Commission, in February 2021, the company issued 11000000 RMB ordinary shares (A shares) to specific investors by means of non-public offering, with a par value of 1.00 yuan per share, an actual issuance price of 40.77 yuan per share and a total raised capital of 44847000000 yuan, After deducting various issuance expenses excluding tax, the total amount is 390807026 yuan, and the net amount of raised funds is 44456192974 yuan.
The above funds were put in place on February 1, 2021. The situation has been verified by Tianzhi International Certified Public Accountants (special general partnership), and the capital verification report (tianzhiye Zi [2021] No. 3563) was issued on February 1, 2021.
(2) Amount used in the current year and year-end balance
The company has used a total of 44474073394 yuan of raised funds and 44474073394 yuan in this year, which are used to supplement working capital. As of December 31, 2021, the balance of the company’s special account for raised funds was RMB 0.00, as follows:
Project amount
The total amount of funds raised on February 1, 2021 is 44847000000 less: issuance expenses 390807026the net amount of funds raised on February 1, 2021 is 44456192974
Project amount
Plus: net amount of interest income and bank wealth management income in 2021 after deducting bank handling charges
